Biotech Breakout - Catalyst Dates: Phase 2/3 data for Taksta (antibiotic) due out near the end of the year.------- I took a very small position on this trade and that made me comfortable holding it when the price dipped. As the price began to downtrend i waited for it to bounce back up so that i can add more shares. But the price continued downward and I eventually sold my shares for a big loss.
$10 Profit
CEMPLong Stock
-$111 Loss
CEMPShort Stock
$236 Profit
CEMPShort Stock
$38 Profit
CEMPShort Stock
$250 Profit
CEMPShort Stock
*Results may not be typical and may vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here.
Never attempt to copy or mirror the trades discussed on this website or in alerts. Attempting to do so may result in substantial financial losses. Alerts are not provided in real-time. For that reason, it is highly unlikely you will be able to buy the stocks at the same entry price, or sell the stocks at the same exit price, to achieve the same or similar profits obtained.
Never attempt to copy or mirror the trades discussed on this website or in alerts. Attempting to do so may result in substantial financial losses. Alerts are not provided in real-time. For that reason, it is highly unlikely you will be able to buy the stocks at the same entry price, or sell the stocks at the same exit price, to achieve the same or similar profits obtained.
